SOUTH SAN FRANCISCO, Calif., June 19 /PRNewswire-FirstCall/ -- Sunesis
Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Eric Bjerkholt,
Sunesis' Senior Vice President, Corporate Development and Finance, will
provide a corporate update at the upcoming Jefferies 2nd Annual Healthcare
Conference at 2:00 p.m. Eastern Time on June 26, 2008 at the Mandarin Oriental
in New York, NY.
Interested parties may access a webcast of the presentation by visiting
the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be
archived on the "Calendar of Events" page in the Investors and Media section
of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a clinical-stage biopharmaceutical company focused on the
development of new oncology therapeutics for the treatment of solid and
hematologic cancers. Sunesis has built a highly experienced cancer drug
development organization committed to advancing its lead product candidate,
voreloxin (formerly SNS-595), in multiple indications to improve the lives of
people with cancer. For additional information on Sunesis Pharmaceuticals,
please visit http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
SOURCE Sunesis Pharmaceuticals, Inc.
